Nifty
Sensex
:
:
14371.90
48878.54
-218.45 (-1.50%)
-746.22 (-1.50%)

Healthcare Services - Diagnostic

Rating :
74/99  (View)

BSE: 539524 | NSE: LALPATHLAB

2298.70
1.90 (0.08%)
22-Jan-2021 | 4:00PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  2280.00
  •  2309.70
  •  2275.30
  •  2296.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  200064
  •  4598.87
  •  2460.00
  •  1179.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 19,134.32
  • 95.65
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 18,565.20
  • 0.52%
  • 16.57

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.23%
  • 0.48%
  • 5.44%
  • FII
  • DII
  • Others
  • 24.37%
  • 7.23%
  • 7.25%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.82
  • 10.95
  • 7.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.75
  • 10.59
  • 5.41

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.74
  • 11.32
  • 9.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 49.56
  • 48.09

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 11.95
  • 11.57

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 30.94
  • 30.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
431.90
365.60
18.13%
266.00
335.20
-20.64%
301.70
301.10
0.20%
327.90
292.50
12.10%
Expenses
304.70
256.70
18.70%
217.70
240.10
-9.33%
244.40
234.90
4.04%
245.60
226.90
8.24%
EBITDA
127.20
108.90
16.80%
48.30
95.10
-49.21%
57.30
66.20
-13.44%
82.30
65.60
25.46%
EBIDTM
29.45%
29.79%
3.55%
3.55%
14.01%
14.01%
25.10%
22.43%
Other Income
12.90
14.80
-12.84%
11.40
14.40
-20.83%
12.00
13.50
-11.11%
13.80
12.20
13.11%
Interest
4.00
3.70
8.11%
3.70
3.80
-2.63%
3.90
0.10
3,800.00%
3.90
0.30
1,200.00%
Depreciation
19.50
17.70
10.17%
17.90
16.30
9.82%
20.00
10.40
92.31%
18.80
9.60
95.83%
PBT
116.60
102.30
13.98%
15.41
15.41
0.00%
45.40
69.20
-34.39%
73.40
67.90
8.10%
Tax
29.50
21.30
38.50%
1.10
1.10
0.00%
12.80
21.80
-41.28%
18.50
21.80
-15.14%
PAT
87.10
81.00
7.53%
14.31
14.31
0.00%
32.60
47.40
-31.22%
54.90
46.10
19.09%
PATM
20.17%
22.16%
37.11%
37.11%
7.11%
7.11%
16.74%
15.76%
EPS
10.24
9.66
6.00%
1.69
1.69
0.00%
28.29
28.29
0.00%
6.49
5.50
18.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,327.50
1,330.36
1,203.42
1,056.92
912.38
791.32
659.59
557.95
451.66
342.21
237.27
Net Sales Growth
2.56%
10.55%
13.86%
15.84%
15.30%
19.97%
18.22%
23.53%
31.98%
44.23%
 
Cost Of Goods Sold
4,849.06
298.70
262.35
226.03
197.08
172.92
139.16
117.66
97.30
76.17
60.87
Gross Profit
-3,521.56
1,031.65
941.07
830.89
715.30
618.40
520.43
440.29
354.36
266.04
176.40
GP Margin
-265.28%
77.55%
78.20%
78.61%
78.40%
78.15%
78.90%
78.91%
78.46%
77.74%
74.35%
Total Expenditure
1,012.40
986.78
909.76
792.92
674.86
583.66
504.44
419.39
354.01
255.69
180.63
Power & Fuel Cost
-
16.74
15.74
15.32
13.58
12.78
11.26
9.65
7.53
5.28
4.27
% Of Sales
-
1.26%
1.31%
1.45%
1.49%
1.62%
1.71%
1.73%
1.67%
1.54%
1.80%
Employee Cost
-
242.64
208.29
180.75
152.01
136.83
134.39
101.57
93.80
53.77
37.79
% Of Sales
-
18.24%
17.31%
17.10%
16.66%
17.29%
20.37%
18.20%
20.77%
15.71%
15.93%
Manufacturing Exp.
-
224.87
196.24
166.22
137.24
18.89
12.90
33.74
25.94
19.62
13.02
% Of Sales
-
16.90%
16.31%
15.73%
15.04%
2.39%
1.96%
6.05%
5.74%
5.73%
5.49%
General & Admin Exp.
-
164.31
188.71
174.12
147.72
220.05
189.85
141.89
118.33
92.63
59.32
% Of Sales
-
12.35%
15.68%
16.47%
16.19%
27.81%
28.78%
25.43%
26.20%
27.07%
25.00%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
39.51
38.43
30.48
27.23
22.18
16.87
14.87
11.12
8.23
0.00
% Of Sales
-
2.97%
3.19%
2.88%
2.98%
2.80%
2.56%
2.67%
2.46%
2.40%
2.26%
EBITDA
315.10
343.58
293.66
264.00
237.52
207.66
155.15
138.56
97.65
86.52
56.64
EBITDA Margin
23.74%
25.83%
24.40%
24.98%
26.03%
26.24%
23.52%
24.83%
21.62%
25.28%
23.87%
Other Income
50.10
55.05
45.95
31.22
27.54
21.84
13.16
8.08
3.38
2.27
2.48
Interest
15.50
15.31
0.84
0.84
0.70
0.50
0.40
0.20
0.44
2.53
0.78
Depreciation
76.20
72.81
38.22
33.06
27.54
28.28
28.19
27.23
20.40
19.83
13.60
PBT
250.81
310.50
300.55
261.31
236.82
200.72
139.72
119.21
80.20
66.42
44.73
Tax
61.90
82.92
100.08
89.56
81.23
67.49
43.28
38.94
24.55
21.25
15.19
Tax Rate
24.68%
26.71%
33.30%
34.27%
34.30%
33.62%
30.98%
32.67%
30.61%
31.99%
33.96%
PAT
188.91
225.94
199.18
170.73
154.59
132.19
95.69
79.58
55.13
44.72
29.12
PAT before Minority Interest
186.31
227.59
200.47
171.75
155.59
133.23
96.44
80.26
55.65
45.17
29.55
Minority Interest
-2.60
-1.65
-1.29
-1.02
-1.00
-1.04
-0.75
-0.68
-0.52
-0.45
-0.43
PAT Margin
14.23%
16.98%
16.55%
16.15%
16.94%
16.70%
14.51%
14.26%
12.21%
13.07%
12.27%
PAT Growth
0.05%
13.44%
16.66%
10.44%
16.95%
38.14%
20.24%
44.35%
23.28%
53.57%
 
Unadjusted EPS
22.68
27.12
23.91
20.50
18.56
15.87
11.49
9.55
6.62
5.37
3.50

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,032.81
945.50
787.85
595.52
507.35
341.08
231.49
162.05
115.97
92.84
Share Capital
83.34
83.34
83.33
83.07
82.68
81.26
80.31
5.02
5.02
5.06
Total Reserves
916.58
834.12
686.58
503.91
423.94
259.82
151.18
157.03
110.95
87.78
Non-Current Liabilities
70.12
-20.25
-8.96
-6.41
12.16
-5.22
1.21
3.37
8.44
9.96
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
4.13
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.20
0.21
0.26
0.05
1.55
1.22
Current Liabilities
227.31
138.30
115.96
84.84
90.78
111.76
97.36
89.09
48.66
63.88
Trade Payables
117.73
79.80
65.45
52.38
42.27
34.16
32.84
31.44
22.71
16.95
Other Current Liabilities
94.03
40.58
40.38
25.37
17.55
58.59
50.44
42.36
7.11
21.22
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.87
0.37
0.01
14.17
Short Term Provisions
15.55
17.93
10.13
7.09
30.97
19.02
13.21
14.92
18.83
11.55
Total Liabilities
1,351.46
1,069.03
898.64
676.39
613.18
449.92
331.90
256.13
174.17
167.33
Net Block
413.02
208.66
207.52
152.43
165.64
150.08
139.83
126.55
108.29
112.33
Gross Block
574.29
301.66
263.71
180.09
335.80
294.82
258.39
218.03
175.49
160.92
Accumulated Depreciation
161.27
93.00
56.19
27.66
170.16
144.74
118.56
91.48
67.20
48.60
Non Current Assets
458.81
255.41
275.61
209.83
189.45
168.24
161.57
139.39
132.22
123.40
Capital Work in Progress
11.38
3.44
9.56
17.51
4.09
0.95
0.17
0.52
6.22
0.03
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
20.38
16.95
16.26
17.79
15.58
13.86
18.78
8.55
8.82
8.31
Other Non Current Assets
14.03
26.36
42.27
22.09
4.13
3.35
2.79
3.76
8.89
2.73
Current Assets
892.65
813.63
623.02
466.56
423.74
281.67
170.33
116.75
41.96
43.94
Current Investments
164.28
184.78
144.80
106.08
64.32
37.92
8.59
54.77
4.77
1.01
Inventories
56.96
28.54
27.34
17.91
14.52
14.28
11.66
8.63
6.23
7.75
Sundry Debtors
51.39
53.22
41.16
41.80
36.31
30.96
25.16
19.79
14.33
9.69
Cash & Bank
569.12
490.24
313.51
239.51
209.95
148.19
105.67
21.46
13.44
22.46
Other Current Assets
50.91
24.39
15.46
12.70
98.64
50.34
19.26
12.10
3.19
3.03
Short Term Loans & Adv.
21.38
32.46
80.76
48.55
88.60
42.87
13.30
9.65
1.39
1.30
Net Current Assets
665.34
675.33
507.06
381.72
332.95
169.91
72.97
27.65
-6.71
-19.94
Total Assets
1,351.46
1,069.04
898.63
676.39
613.19
449.91
331.90
256.14
174.18
167.34

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
283.89
218.54
197.06
171.31
158.54
121.77
97.96
88.13
68.13
41.79
PBT
310.50
300.55
261.31
155.59
200.72
139.72
119.21
80.20
66.42
44.73
Adjustment
54.69
12.96
20.86
94.46
7.98
43.68
38.46
44.15
22.20
13.34
Changes in Working Capital
12.17
9.30
8.93
-8.13
18.55
-8.20
-9.45
-2.81
-0.04
0.18
Cash after chg. in Working capital
377.36
322.81
291.10
241.92
227.24
175.20
148.22
121.53
88.58
58.25
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-93.47
-104.28
-94.03
-70.61
-68.69
-53.43
-50.26
-33.40
-20.46
-16.46
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-26.11
-99.74
-172.28
-137.11
-163.49
-113.45
-89.69
-65.03
-26.25
-18.59
Net Fixed Assets
-195.23
-29.28
-71.11
146.62
-43.19
-35.86
-63.09
-18.58
-20.76
Net Investments
-38.73
-40.48
-39.28
-60.10
-24.82
-29.33
60.23
-57.58
-3.76
Others
207.85
-29.98
-61.89
-223.63
-95.48
-48.26
-86.83
11.13
-1.73
Cash from Financing Activity
-190.44
-55.26
12.51
-32.26
0.36
-0.80
-10.20
-14.80
-38.34
-22.15
Net Cash Inflow / Outflow
67.33
63.54
37.30
1.94
-4.59
7.52
-1.93
8.30
3.53
1.04
Opening Cash & Equivalents
129.39
65.85
28.55
26.61
23.28
15.76
17.30
7.98
4.45
3.25
Closing Cash & Equivalent
196.72
129.39
65.85
28.55
18.70
23.28
15.76
17.30
7.98
4.45

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
119.97
110.08
92.39
70.66
61.28
57.56
38.16
29.88
21.30
16.80
ROA
18.81%
20.38%
21.81%
24.13%
25.06%
24.67%
27.30%
25.86%
26.45%
17.66%
ROE
23.74%
23.76%
25.32%
28.45%
32.45%
37.14%
43.95%
40.52%
43.96%
32.41%
ROCE
32.94%
34.78%
37.90%
43.07%
47.43%
48.87%
60.49%
57.93%
60.36%
40.46%
Fixed Asset Turnover
3.04
4.26
4.76
3.54
2.51
2.38
2.34
2.30
2.03
1.47
Receivable days
14.35
14.31
14.32
15.62
15.51
15.53
14.70
13.78
12.81
14.90
Inventory Days
11.73
8.47
7.81
6.49
6.64
7.18
6.64
6.00
7.46
11.93
Payable days
41.84
36.52
34.38
32.53
37.45
37.29
40.25
40.11
41.19
47.33
Cash Conversion Cycle
-15.76
-13.73
-12.25
-10.42
-15.30
-14.59
-18.91
-20.33
-20.92
-20.51
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.21
Interest Cover
21.28
359.22
311.72
340.29
404.57
346.20
603.05
183.69
27.24
58.13

News Update


  • Dr. Lal PathLabs’ arm signs binding term sheets
    6th Nov 2020, 15:38 PM

    BDL and CDSPL are engaged in the business of providing pathological diagnostic services

    Read More
  • Dr Lal Pathlabs - Quarterly Results
    6th Nov 2020, 14:35 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.